Facebook Linkedin RSS Twitter Youtube
Home 2023

Cancer testing

At JPM, Illumina Announces African-American Sequencing Collaboration
Cancer

At JPM, Illumina Announces African-American Sequencing Collaboration

Test May Predict Recurrence and Response to Immunotherapy in Melanoma Patients
Cancer

Test May Predict Recurrence and Response to Immunotherapy in Melanoma Patients

Whole-Exome Sequencing Predicts Response to Cancer Immunotherapy
News

Whole-Exome Sequencing Predicts Response to Cancer Immunotherapy

Cancer Drug Response and Outcome Predicted from Cell Mass Changes
Cancer

Cancer Drug Response and Outcome Predicted from Cell Mass Changes

AI Blood Test Shown to Detect >90% of Lung Cancers Across Different Stages
Artificial Intelligence

AI Blood Test Shown to Detect >90% of Lung Cancers Across Different Stages

Looking Beyond NIPT, Natera Eyes Cancer, Transplant Testing Growth
Drug Discovery

Looking Beyond NIPT, Natera Eyes Cancer, Transplant Testing Growth

Illumina to Acquire Cancer Blood Test Developer GRAIL for $8B
Cancer

Illumina to Acquire Cancer Blood Test Developer GRAIL for $8B

Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with Up-to-$1.4B ArcherDx Acquisition
Cancer

Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with Up-to-$1.4B ArcherDx Acquisition

Artificial Intelligence Improves Ovarian Cancer Prognosis
Artificial Intelligence

Artificial Intelligence Improves Ovarian Cancer Prognosis

Pancreatic Cancer Diagnosis on the Tip of Your Tongue…Microbiome
Cancer

Pancreatic Cancer Diagnosis on the Tip of Your Tongue…Microbiome

123...5Page 2 of 5
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.